Tag: Healthcare Innovation Award

Tumusifu Manegabe Jean de Dieu | Medicine and Dentistry | Life Sciences Innovation Award

Published on by World Science Awards

Dr. Tumusifu Manegabe Jean de Dieu | Medicine and Dentistry | Life Sciences Innovation Award

Resident at Catholic university of Bukavu, Congo, Democratic Republic of the

Dr. Tumusifu Manegabe Jean de Dieu is a skilled medical doctor with extensive education and training in medicine, surgery, and public health. He earned his medical degree from Université Catholique de Bukavu in the Democratic Republic of Congo and has been actively involved in clinical practice, particularly in general surgery. Dr. Tumusifu has contributed to several research publications, including case reports on sacrococcygeal teratoma and bladder exstrophy, and systematic reviews in fields like oncology and neurology. He has participated in important health initiatives, such as the Ebola virus vaccination campaign, demonstrating his commitment to addressing public health challenges. Proficient in French, Swahili, and English, Dr. Tumusifu also excels in teamwork, problem-solving, and leadership, having held key student leadership roles during his education. With strong clinical and research experience, he has the potential to contribute significantly to innovative developments in life sciences and healthcare.

Profile

Education

Dr. Tumusifu Manegabe Jean de Dieu holds a comprehensive educational background in the medical sciences. He earned his Medical Doctor degree from the Université Catholique de Bukavu (UCB) in the Democratic Republic of Congo (DRC) in December 2019, following rigorous Bachelor’s studies in Medicine from 2015 to 2019. Prior to this, Dr. Tumusifu completed his undergraduate degree in Biomedical Sciences at the same institution, graduating with distinction in July 2015. His foundational academic journey began at EDAP/ISP, Bukavu, where he earned his State Diploma in Chemistry-Biology in 2012, ranking first in his class. Dr. Tumusifu’s early education also saw him excel at AVENIR Primary School in Bukavu, where he graduated with top honors. His academic path reflects a commitment to excellence and a solid grounding in both medical and biological sciences, positioning him well for his residency and further clinical training.

Professional Experience

Dr. Tumusifu Manegabe Jean de Dieu has extensive experience in the medical field, particularly in surgery and public health. Since July 2020, he has been a resident in general surgery at the Hopital Provincial General de Reference de Bukavu (HPGRB), where he also completed his clinical training and internships in surgery, internal medicine, pediatrics, obstetrics, and gynecology. His training spans multiple institutions, including clinical roles in neuropsychiatry, public health, and nursing. Dr. Tumusifu has also contributed to various public health initiatives, including the Ebola virus vaccination campaign in Bukavu, and led a nutritional survey in the Nyangezi Health Zone. He has actively participated in numerous international medical symposia, further enriching his professional development. His diverse experience highlights his adaptability and dedication to improving healthcare in resource-limited settings, making him a well-rounded medical professional with hands-on expertise in a wide range of medical disciplines.

Research Skills

Dr. Tumusifu Manegabe Jean de Dieu possesses a solid foundation in research, particularly in clinical and surgical fields. His research skills are demonstrated through his contributions to peer-reviewed journals, focusing on complex medical conditions like sacrococcygeal teratoma and bladder exstrophy. He has experience in conducting systematic reviews and meta-analyses, contributing to evidence-based medical research. Additionally, Dr. Tumusifu has actively participated in public health research, including leading a nutritional survey and investigating Ebola virus belt vaccination, showcasing his capability in field research and data collection. His proficiency with statistical software such as SPSS, R, and STATA enhances his ability to analyze and interpret data effectively. Dr. Tumusifu’s collaborative research efforts, combined with his leadership in healthcare surveys and clinical studies, underscore his commitment to advancing medical knowledge and improving healthcare outcomes in resource-limited settings. His research skills make him a valuable contributor to the medical and public health research community.

Award and Recognition

Dr. Tumusifu Manegabe Jean de Dieu is an emerging medical professional with notable achievements in both clinical practice and research. His dedication to improving healthcare in resource-constrained settings is exemplified by his published case studies on rare and complex medical conditions such as sacrococcygeal teratoma and bladder exstrophy. Dr. Tumusifu has also been actively involved in critical global health efforts, including his participation as an investigator in the Ebola vaccination belt campaign. His leadership roles, including serving as Chief Staff of the Student Representative at the Université Catholique de Bukavu, further highlight his commitment to medical advancement and collaborative teamwork. His participation in prestigious symposiums such as the 2nd Incision Global Surgery Symposium underscores his engagement with the global medical community. Dr. Tumusifu’s research outputs and contributions to medical literature have positioned him as a promising figure in life sciences, earning him recognition in both academic and clinical fields.

Conclusion

Dr. Tumusifu has a strong foundation in medical practice, research, and leadership, making him a promising candidate for the Research for Life Sciences Innovation Award. However, further development in cutting-edge research methodologies and independent research leadership could elevate his contributions to align more closely with the innovative breakthroughs typically associated with this award. With some additional focus on advanced research skills and leadership in innovation projects, he has the potential to excel in this domain.

 

 

 

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79

 

 

Royston Liew | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623

 

Hyun-Soo Choi | Medical Domain | Best Researcher Award

Published on by World Science Awards

Prof Dr. Hyun-Soo Choi | Medical Domain | Best Researcher Award

Assistant Professor at Seoul National University of Science and Technology, South Korea

Dr. Hyun-Soo Choi is an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology. He holds a Ph.D. in Electrical and Computer Engineering from Seoul National University. His research focuses on artificial intelligence, machine learning, deep learning, biomedical data learning, and causal inference. With significant contributions to the field, Dr. Choi has published extensively in renowned journals, including IEEE Transactions on Neural Networks and Learning Systems and the Journal of Clinical Medicine. His work on deep learning-based medical diagnostics and imbalanced data classification has garnered attention for its innovative approaches and practical applications. In addition to his academic role, he serves as the Chief Technical Officer at Ziovision and has previously worked as a researcher at SK Telecom. Dr. Choi has received accolades such as the Annual Excellence Award from Seoul National University, recognizing his impactful research and academic achievements.

Profile

Education

Dr. Hyun-Soo Choi’s educational journey is marked by distinguished achievements and a solid foundation in engineering and computer science. He earned his Bachelor of Science degree in Computer and Communication Engineering from Korea University in February 2013, where he developed a strong base in computing principles. He then pursued advanced studies at Seoul National University, completing his Ph.D. in Electrical and Computer Engineering in February 2020. During his doctoral studies, he was supervised by Prof. Sungroh Yoon and focused on “Imbalanced Data Learning: Advances in Techniques and Applications,” contributing significant advancements to the field of artificial intelligence and machine learning. This academic background not only reflects his expertise in data analysis and bio-medical data learning but also highlights his commitment to advancing knowledge through innovative research.

Professional Experience

Dr. Hyun-Soo Choi has accumulated a diverse range of professional experiences across academia and industry. Currently, he serves as an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology since February 2023. In this role, he teaches advanced courses in programming, natural language processing, and deep learning. Concurrently, Dr. Choi is the Chief Technical Officer at Ziovision, overseeing technological innovations and developments since October 2021. Previously, he was an Assistant Professor at Kangwon National University from March 2021 to February 2023, where he contributed to various courses on data analysis and machine learning. Dr. Choi also has experience as a researcher at SK Telecom’s T-brain, focusing on advanced artificial intelligence applications from February 2020 to February 2021. His academic background includes a Ph.D. from Seoul National University, where he was mentored by Prof. Sungroh Yoon.

 Research Interest

Dr. Hyun-Soo Choi’s research focuses on advanced artificial intelligence (AI) and machine learning techniques, with a particular emphasis on deep learning, universal learning machines, and causal inference. His work addresses the challenges of bio-medical data learning, aiming to enhance the accuracy and efficiency of data-driven healthcare solutions. Dr. Choi’s research contributions include developing innovative algorithms for imbalanced data learning and applying deep learning methods to various medical fields, such as organ localization and ECG analysis. His recent projects explore novel approaches in facial fracture detection, drug monitoring, and real-time health monitoring, underscoring his commitment to translating AI advancements into practical medical applications. By integrating interdisciplinary methodologies, Dr. Choi strives to push the boundaries of AI research, improving diagnostic and predictive capabilities in healthcare and beyond.

 Research Skills

Dr. Hyun-Soo Choi exhibits a broad and advanced skill set in artificial intelligence and machine learning, particularly in deep learning, causal inference, and bio-medical data analysis. His expertise spans a range of research techniques, including the development of advanced algorithms for imbalanced data learning and generative adversarial networks (GANs). Dr. Choi is proficient in employing deep learning models for diverse applications, such as facial fracture detection, organ localization in wireless capsule endoscopy, and electrocardiography analysis. His ability to integrate machine learning methods with real-world medical data demonstrates a strong aptitude for translating complex theoretical models into practical solutions. Additionally, Dr. Choi’s experience with causal inference methods and universal learning machines highlights his skill in handling intricate data structures and extracting meaningful insights. His comprehensive understanding of these areas is evident through his numerous high-impact publications and contributions to cutting-edge research in his field.

Conclusion

Dr. Hyun-Soo Choi is a strong candidate for the “Research for Best Researcher Award” due to his prolific research output, interdisciplinary expertise, and leadership roles in both academia and industry. However, to further strengthen his application, it would be beneficial to highlight his success in securing research funding, previous awards or recognitions, mentorship activities, and the broader societal impact of his research. With these additions, Dr. Choi would present a well-rounded profile that exemplifies excellence in research and its application to solving real-world challenges.

 

Publications Top Notes

  • A Comprehensive Study on a Deep-Learning-Based Electrocardiography Analysis for Estimating the Apnea-Hypopnea Index
    • Authors: Kim, S., Choi, H.-S., Kim, D., … Kim, Y., Lee, W.H.
    • Year: 2024
  • A Deep Learning–Based Approach for Prediction of Vancomycin Treatment Monitoring: Retrospective Study Among Patients With Critical Illness
    • Authors: Kim, D., Choi, H.-S., Lee, D., … Park, J.-H., Park, J.
    • Year: 2024
    • Citations: 1
  • Early Prediction of Mortality for Septic Patients Visiting Emergency Room Based on Explainable Machine Learning: A Real-World Multicenter Study
    • Authors: Park, S.W., Yeo, N.Y., Kang, S., … Lim, C.-M., Heo, J.
    • Year: 2024
    • Citations: 2
  • Explicit Feature Interaction-Aware Graph Neural Network
    • Authors: Kim, M., Choi, H.-S., Kim, J.
    • Year: 2024
    • Citations: 1
  • In-Advance Prediction of Pressure Ulcers via Deep-Learning-Based Robust Missing Value Imputation on Real-Time Intensive Care Variables
    • Authors: Kim, M., Kim, T.-H., Kim, D., … Han, S.-S., Choi, H.-S.
    • Year: 2024
  • Improving Generalization Performance of Electrocardiogram Classification Models
    • Authors: Han, H., Park, S., Min, S., … Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • On the Impact of Knowledge Distillation for Model Interpretability
    • Authors: Han, H., Siwon, K., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 1
  • Multi-View Computed Tomography Network for Osteoporosis Classification
    • Authors: Hwang, D.H., Bak, S.H., Ha, T.-J., … Kim, W.J., Choi, H.-S.
    • Year: 2023
    • Citations: 1
  • PixelSteganalysis: Pixel-Wise Hidden Information Removal With Low Visual Degradation
    • Authors: Jung, D., Bae, H., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • ConBERT: A Concatenation of Bidirectional Transformers for Standardization of Operative Reports from Electronic Medical Records
    • Authors: Park, S., Bong, J.-W., Park, I., … Choi, H.-S., Kang, S.
    • Year: 2022
    • Citations: 1

 

Younhee Kang | Clinical Reasoning Competence | Best Researcher Award

Published on by World Science Awards

Dr. Younhee Kang | Clinical Reasoning Competence | Best Researcher Award

Professor, Ewha Womans University, South Korea.

Dr. Younhee Kang is a distinguished academic and leader in nursing science with extensive experience at Ewha Womans University, where she has held prominent roles including Dean and Professor. Her research, supported by significant grants from the National Research Foundation of Korea and other agencies, focuses on advanced health prediction models and community-based health programs. Dr. Kang’s leadership extends to key positions in professional organizations, including Sigma Theta Tau International and the Korean Nurses Association. She has been recognized with awards for her teaching excellence and contributions to research. Her active involvement in editorial and review roles further underscores her expertise. While her achievements are notable, expanding the global impact of her research and diversifying her focus could enhance her profile. Overall, Dr. Kang’s extensive contributions and leadership make her a compelling candidate for the Research for Best Researcher Award.

Profile
Education

Dr. Younhee Kang’s educational background reflects a robust foundation in nursing and healthcare education. She earned her Bachelor of Science in Nursing (BSN) from Ewha Womans University in Seoul, Korea, in 1994. Her pursuit of advanced studies led her to the Frances Payne Bolton School of Nursing at Case Western Reserve University in Cleveland, Ohio, where she completed both her Master of Science in Nursing (MSN) with a focus on Advanced Nurse Practitioner (ANP) and her Doctor of Philosophy (Ph.D.) in Nursing. Her doctoral dissertation, completed in 2002, investigated the interplay of uncertainty, illness severity, and social support in patients newly diagnosed with atrial fibrillation. Dr. Kang’s educational journey culminated with a Ph.D. in Education from Ewha Womans University in 2013, further enhancing her expertise and commitment to advancing nursing education and practice.

Professional Experience

Dr. Younhee Kang has an impressive professional trajectory in nursing and academia. Currently serving as the Dean of the College of Nursing at Ewha Womans University since February 2022, she previously held significant roles including Associate Vice President of Admission Information and Associate Dean of the College of Health Sciences at the same institution. Dr. Kang’s extensive experience includes positions as Professor and Division Chair at Ewha Womans University, and roles as Assistant Professor and Research Assistant at Kyungpook National University and Case Western Reserve University. Her leadership extends to various committees and boards, such as the Korean Accreditation Board of Nursing and Sigma Theta Tau International. Dr. Kang’s career reflects a robust commitment to advancing nursing education, research, and professional practice, underscored by her active involvement in shaping healthcare policy and education on a national and international level.

Research Interest

Dr. Younhee Kang’s research interests are centered on advancing nursing science through innovative approaches and technology integration. Her work focuses on developing predictive models for health outcomes, such as the AI-based diabetic neuropathy foot prediction model and nursing workload prediction using AICBM technology. She is deeply invested in community-based health promotion programs, particularly in women’s health and active aging projects. Her research also explores the impact of unification on nursing systems, emphasizing the perception of nurses and nursing students. Dr. Kang’s studies aim to enhance health interventions and systems through evidence-based practices and cutting-edge technology, reflecting her commitment to improving patient care and healthcare delivery. Her interdisciplinary approach and dedication to addressing current healthcare challenges position her as a leading researcher in the field of nursing and healthcare.

Research Skills

Dr. Younhee Kang possesses a diverse array of research skills that underscore her expertise in nursing science and healthcare. Her research acumen is demonstrated through her leadership in high-impact projects, such as the development of AI-based health prediction models and community health promotion programs. She excels in securing substantial research funding from prominent agencies, reflecting her ability to design and propose innovative research initiatives. Dr. Kang’s proficiency extends to managing complex research projects, including the validation of health technologies and prediction models for nursing workloads. Her extensive experience as a reviewer and editor for esteemed journals further highlights her analytical skills and in-depth knowledge of the field. Additionally, her roles in various professional committees and organizations showcase her ability to translate research findings into practical applications and policy advancements, reinforcing her influential role in shaping nursing science and healthcare practices.

Awards and Recognition

Dr. Younhee Kang has received notable awards and recognition throughout her distinguished career. She was honored with the Dr. Susie Kim Dissertation Scholarship in 2001 and the Excellent Lecturer’s Award from Ewha Womans University in 2009, highlighting her exceptional teaching. In 2015, she was recognized for her decade of continuous service at Ewha Womans University. Her contributions to scholarly peer review were acknowledged when she was named an Excellent Reviewer by the Journal of Korean Academy of Nursing in 2016. These accolades reflect her commitment to advancing nursing science through both her teaching and research endeavors, underscoring her significant impact on the field and her dedication to excellence in academia.

Conclusion

Dr. Younhee Kang is a highly accomplished candidate for the Research for Best Researcher Award. Her extensive leadership roles, significant research funding, and contributions to professional organizations underscore her impact and dedication to nursing science. Enhancing the global reach of her research and diversifying her focus could further solidify her standing as a leading researcher in her field. Given her track record of success and ongoing contributions, she is a strong contender for the award.

Publications Top Notes

  1. An exploratory study of the practical impact of the COVID-19 pandemic on nursing tasks in clinical settings
    • Authors: Kang, Y., Hwang, H.
    • Year: 2024
  2. Asian Cohort for Alzheimer’s Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer’s disease among Asian Americans and Canadians
    • Authors: Ho, P.-C., Yu, W.H., Tee, B.L., Chow, T.W., Wang, L.-S.
    • Year: 2024
    • Citations: 2
  3. Diabetes self-care activities and its correlates in patients with diabetic neuropathy
    • Authors: Kang, Y., Park, I.
    • Year: 2024
  4. Korean nurses’ energy drink consumption and associated factors
    • Authors: Kang, Y., Yang, I.-S.
    • Year: 2023
    • Citations: 3
  5. A comparison of dementia care and policy in five Asian regions: A literature review
    • Authors: Kang, Y., Jung, D., Lee, J.J., Hur, Y., Yoo, L.
    • Year: 2023
  6. Factors contributing to chronic obstructive pulmonary disease patients’ functional performance: Structural equation modelling based on theory of unpleasant symptoms
    • Authors: Jun, H.S., Kang, Y.
    • Year: 2023
    • Citations: 2
  7. The impact of changes in nursing practicum caused by COVID-19 pandemic on new graduate nurses
    • Authors: Kang, Y., Hwang, H.
    • Year: 2023
    • Citations: 5
  8. Suggestion for item allocation to 8 nursing activity categories of the Korean Nursing Licensing Examination: a survey-based descriptive study
    • Authors: Kimi, K., Kang, S.Y., Kang, Y., Choi, M.-Y., Lee, H.S.
    • Year: 2023
  9. Development of international nursing standard–based curriculum for North Korean nurses
    • Authors: Kang, Y., Yang, I., Lee, E., Bang, C.
    • Year: 2022
  10. Evaluating the cutoff score of the advanced practice nurse certification examination in Korea
    • Authors: Kang, Y.
    • Year: 2022

 

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Clinical/Research Fellow of Barts Health NHS Trust, United Kingdom.

Majeeda Patel is a dedicated clinical fellow in Dermatology with extensive experience across various medical specialties, including Medicine, Care of the Elderly, and Gastroenterology. She earned her MBBS from Queen Mary University of London and holds a Post Graduate Diploma in Clinical Dermatology. Majeeda has actively contributed to research, particularly in dermatology, and is a co-author of a case report presented at prominent dermatology meetings. Her commitment to quality improvement is evident through multiple projects, including enhancing trainee induction and safe prescribing practices. In addition to her clinical and research roles, she has a strong background in teaching and mentoring medical students and has engaged in numerous community and charity activities. Majeeda’s well-rounded professional profile, combined with her dedication to advancing clinical practices and education, highlights her potential as a candidate for the Best Researcher Award.

Profile
Education

Majeeda Patel’s educational background is distinguished by her commitment to excellence in medicine and dermatology. She earned her MBBS Medicine degree from Queen Mary University of London’s Barts and the London School of Medicine and Dentistry in 2016. Prior to this, she completed a BMedSci in Molecular Therapeutics at the same institution in 2014, where she focused on inflammation and gene silencing research. Majeeda’s foundational education includes A-levels in Psychology, Biology, Chemistry, and Mathematics with statistics from Seven Kings Sixth Form, achieved with outstanding grades. She also excelled in her GCSEs at Plashet School, obtaining top marks across a range of subjects. Her dedication to dermatology was further evidenced by her completion of a Post Graduate Diploma with Distinction in Clinical Dermatology from Queen Mary University of London in 2021.

Professional Experience

Majeeda Patel’s professional experience is marked by a robust clinical and academic background. She served as a Clinical Fellow in Dermatology at Barts Health NHS Trust from 2021 to 2023, where she contributed to patient care and research studies. Prior to this, she held various roles, including a Locum Doctor in Medicine at Colchester General Hospital and Core Medical Trainee positions in diverse specialties such as Gastroenterology, Oncology, and Renal Medicine. Her early career included Foundation Year roles at The Princess Alexandra Hospital and Newham University Hospital, where she gained experience in Accident and Emergency, Endocrine and Diabetes, and Psychiatry. Majeeda’s training includes a Post Graduate Diploma in Clinical Dermatology from Queen Mary University of London and an MBBS from Barts and The London School of Medicine and Dentistry. Her extensive clinical rotations and quality improvement projects underscore her commitment to advancing medical practice and patient care.

Research Interest

Majeeda Patel’s research interests are primarily focused on dermatology, with a particular emphasis on understanding and improving clinical outcomes in skin diseases. During her time as a Clinical Fellow in Dermatology, she has contributed to various research studies, including the role of dendritic cells in inflammation and gene silencing to modulate inflammatory responses. Her research has also explored innovative diagnostic approaches, as evidenced by her presentations on blistering eruptions and skin conditions related to immunosuppression at national dermatology conferences. Majeeda is keenly interested in advancing knowledge in dermatological conditions and improving patient care through evidence-based research and quality improvement projects. Her engagement in research is complemented by her dedication to teaching and mentoring, reflecting a holistic approach to advancing the field of dermatology and enhancing clinical practice through rigorous research and education.

Research Skills

Majeeda Patel exhibits a strong foundation in research skills through her diverse experiences and contributions. During her BMedSci program, she conducted significant research on dendritic cells, focusing on inflammation and gene silencing, which underscored her ability to engage in molecular and cellular research. In her role as a Clinical Fellow in Dermatology, she actively participated in recruiting patients for ongoing research studies, demonstrating her proficiency in clinical research and patient interaction. Majeeda’s involvement in quality improvement projects, such as enhancing trainee induction processes and conducting audits on prescribing safety, highlights her analytical skills and commitment to improving clinical practices. Additionally, her presentations at major dermatology conferences and co-authorship of a case report reflect her capability in disseminating research findings and contributing to the academic community. Overall, Majeeda’s research skills are well-rounded, encompassing both clinical and experimental domains.

Awards and Recognition

Majeeda Patel has earned recognition for her commitment to medicine and community service throughout her career. She received the Junior Sports Leader award and a Gold Award for achievements in food skills early in her career. Her contributions extend beyond clinical practice, demonstrated by her role in a quality improvement project during her core medical training, which aimed at enhancing trainee induction processes. Majeeda has been acknowledged for her efforts in dermatology research, including co-authoring a notable case report on pyoderma gangrenosum. Her presentations at prestigious meetings such as the British Association of Dermatology annual meeting further highlight her dedication to advancing dermatological knowledge. Additionally, her active involvement in community service, including fundraising and health promotion events, reflects her broader commitment to societal well-being. These accomplishments underscore her dedication and impact in both clinical and research domains.

Conclusion

Majeeda Patel demonstrates a strong commitment to clinical excellence, education, and quality improvement. Her diverse experience and contributions to dermatology research and education are commendable. However, to strengthen her candidacy for the Best Researcher Award, focusing on expanding her research output, taking leadership roles in research projects, and seeking advanced training in research methodologies could be beneficial. Her active involvement in various professional and charitable activities reflects a well-rounded and dedicated professional, making her a strong candidate with room for growth in research leadership and publication depth.

Publications Top Notes

  1. Differences in frequency of vulvar dermatoses according to ethnicity: A study of a cohort of patients in a large diverse UK teaching hospital
    • Authors: Majeeda Patel, Jade Simpson, Beth Stuart, Sujatha Thamban, Arucha Ekeowa‐Anderson
    • Year: 2024
  2. First presentation of pyoderma gangrenosum in a patient with partial immunoglobulin A deficiency
    • Authors: S Demirel, M Shetty, M Patel, K Mahmood
    • Year: 2022

 

 

Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Research Assistant of Tabriz university of medical sciences, Iran.

Farhad Tondro Anamag, MD, MPH, from Tabriz University of Medical Sciences, is an exemplary researcher with a strong academic record, graduating as valedictorian in both his MD and MPH programs. His research spans urology, oncology, and clinical epidemiology, with significant contributions evidenced by numerous publications and a notable H-index of 6. Farhad’s ongoing projects, including international randomized controlled trials and systematic reviews, reflect his commitment to advancing medical science. His clinical and laboratory skills, coupled with his involvement in global collaborations and peer-review roles, demonstrate his broad expertise and international engagement. Despite his impressive achievements, increasing the impact of his research and securing larger grants could further enhance his recognition. Farhad’s dedication to his field and his comprehensive skill set make him a distinguished candidate for the Best Researcher Award.

Profile
Education

Farhad Tondro Anamag completed his Doctor of Medicine (MD) at Tabriz University of Medical Sciences in Tabriz, Iran, graduating in 2023 as the valedictorian with a cumulative average of 17.14/20. His thesis focused on the burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa, based on the global burden of disease study 2019. Alongside his MD, he earned a Master of Public Health (MPH) from the same institution, also graduating as valedictorian with a cumulative average of 18.14/20. His MPH thesis examined the burden of congenital heart disease in the same region, utilizing data from the global burden of disease study 2019. Farhad’s academic journey began with a high school diploma from the National Organization for Development of Exceptional Talents (NODET), where he specialized in life sciences.

Professional Experience

Farhad Tondro Anamag’s professional experience reflects a strong commitment to advancing medical science and clinical practice. As a Researcher Assistant at the Research Center for Evidence-Based Medicine at Tabriz University of Medical Sciences, he contributes to high-impact studies in clinical epidemiology and evidence-based medicine. Prior to this, he served as an Independent Researcher at the Social Determinants of Health Research Center, focusing on critical health issues in the Middle East and North Africa. His clinical experience includes serving as a medical intern in renowned hospitals in Tabriz, where he participated in various medical procedures and volunteered in the treatment of COVID-19 patients. Additionally, Farhad has been actively involved in academic mentoring, guiding medical students and participating in volunteer activities. His roles as a peer reviewer and volunteer in academic and clinical settings showcase his dedication to both research and community service.

Research Interest

Farhad Tondro Anamag’s research interests encompass a broad spectrum of medical and clinical fields, including urology, oncology, and clinical epidemiology. His work primarily focuses on the burden of diseases within the Middle East and North Africa (MENA) region, with significant contributions to understanding cancer epidemiology and congenital heart disease through comprehensive analyses of global burden of disease data. Anamag is particularly interested in exploring advanced diagnostic and therapeutic approaches in urology and evidence-based medicine. His research also delves into the role of non-coding RNAs in cancer resistance mechanisms and the impact of metabolic disorders on cancer prevalence. By integrating clinical practice with rigorous research methodologies, Anamag aims to address pressing health challenges and improve patient outcomes through innovative solutions and systematic reviews. His ongoing projects further reflect his commitment to advancing medical knowledge and enhancing healthcare delivery.

Research Skills

Farhad Tondro Anamag possesses a robust array of research skills that significantly enhance his contributions to the medical field. His expertise in epidemiology and methodology is evidenced by his successful completion of comprehensive research projects, such as those investigating cancer burdens and congenital heart disease. Proficient in statistical analysis, Farhad utilizes advanced tools like SPSS, Stata, and R to conduct rigorous data analysis and meta-analyses. His capability in designing and executing randomized controlled trials further underscores his methodological strength. Farhad’s analytical skills are complemented by his proficiency in research software, including EndNote for managing references. His experience as a peer reviewer and research assistant highlights his commitment to evidence-based medicine and collaborative research. Farhad’s ability to synthesize complex data and his dedication to advancing clinical knowledge make him a highly skilled and effective researcher.

Awards and Recognition

Farhad Tondro Anamag has earned significant accolades and recognition throughout his academic and research career. Notably, he ranked in the top 2.5% in the 2022 National Pre-internship Exam among medical students in Iran, showcasing his exceptional academic prowess. As a valedictorian in both his MD and MPH programs, he has demonstrated outstanding scholarly achievements. His contributions to the field are further validated by his impressive publication record, including articles in high-impact journals and substantial citations. Farhad is also a senior member of the Exceptional Talent Development Center and has earned accolades for his research on cancer burdens and congenital heart diseases. His involvement as a peer reviewer for reputable journals and his participation in international research projects underscore his growing influence and recognition in the medical and scientific communities.

Conclusion

Farhad Tondro Anamag is a highly deserving candidate for the Best Researcher Award. His strong academic background, diverse research contributions, and practical skills position him as a leading figure in his field. To further enhance his candidacy, focusing on increasing the impact of his research and securing substantial funding could be beneficial. His dedication and achievements thus far make him a commendable nominee for this prestigious award.

Publications Top Notes

  • Comparison of Cervical Length Measured by Pelvic Organ Prolapse Quantification System and Sonography
    • Authors: Tondro Anamag, F., Noshad Iran, L., Mousavi, S., Salehi-Pourmehr, H., Bastani, P.
    • Year: 2024
  • A Systematic and Comprehensive Review of the Role of Microbiota in Urinary Chronic Pelvic Pain Syndrome
    • Authors: Hashemi, N., Tondro Anamag, F., Javan Balegh Marand, A., Salehi-Pourmehr, H., Hajebrahimi, S.
    • Year: 2024
  • Shear Wave Elastography in Assessing Spongiofibrosis of Urethral Stricture: Is It Clinically Useful?
    • Authors: Tondro Anamag, F., Sedigh, O., Tarzamni, M.K., Soleimanzadeh, F., Hosseini, J.
    • Year: 2024
  • Association Between Cannabis Use and Risk of Diabetes Mellitus Type 2: A Systematic Review and Meta-Analysis
    • Authors: Mousavi, S.E., Tondro Anamag, F., Sanaie, S.
    • Year: 2023
    • Citations: 4
  • Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019
    • Authors: Tondro Anamag, F., Noori, M., Nejadghaderi, S.A., Kolahi, A.-A., Safiri, S.
    • Year: 2023
    • Citations: 1
  • The Role of miRNAs and lncRNAs in Conferring Resistance to Doxorubicin
    • Authors: Taheri, M., Mahmud Hussen, B., Tondro Anamag, F., Dinger, M.E., Ghafouri-Fard, S.
    • Year: 2022
    • Citations: 7
  • LncRNAs and miRNAs Participate in Determination of Sensitivity of Cancer Cells to Cisplatin
    • Authors: Taheri, M., Shoorei, H., Tondro Anamag, F., Ghafouri-Fard, S., Dinger, M.E.
    • Year: 2021
    • Citations: 34
  • The Emerging Role of Non-Coding RNAs in the Regulation of PI3K/AKT Pathway in the Carcinogenesis Process
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Majidpoor, J., Taheri, M.
    • Year: 2021
    • Citations: 50
  • 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Basiri, A., Taheri, M.
    • Year: 2021
    • Citations: 79

 

Marine Gogia | Medicine | Best Researcher Award

Published on by World Science Awards

Dr. Marine Gogia | Medicine | Best Researcher Award

Program Director at Georgian Harm Reduction Network, Georgia.

Dr. Marine Gogia is a distinguished Public Health Specialist and Patient Advocate with extensive experience in harm reduction and epidemiology. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, following her Master’s in Public Health from the University of Georgia. Dr. Gogia’s career highlights include her role as Programs Director at the Georgian Harm Reduction Network, where she manages significant projects like the Global Fund initiative targeting HIV/AIDS prevention and harm reduction. Her research encompasses HIV self-testing, hepatitis C treatment, and risk behavior assessments among marginalized groups. Dr. Gogia’s contributions extend to her leadership roles with the European AIDS Treatment Group and various international health organizations. She has been recognized for her impactful research and advocacy, which include numerous publications and presentations at global conferences.

Profile
Education

Dr. Marine Gogia is a highly educated public health specialist with a strong academic background. She is currently pursuing a Ph.D. in Public Health and Epidemiology at Tbilisi State University and SUNY Albany, USA (2022-2025). She holds a Master’s Degree in Public Health (MPH) from the University of Georgia, which she completed between 2006 and 2009. Dr. Gogia’s foundational education was at Tbilisi State Medical University, where she studied Preventive Medicine (1996-2002). Her commitment to continuing education is evident from her participation in specialized courses, including the European Patients Academy (EUPATI) Expert Patients Course (2017-2018) and the EATG Training Academy’s STEP-UP program (2014-2015). This extensive educational background has equipped her with a robust understanding of public health, epidemiology, and the skills necessary to address complex health challenges effectively.

Professional Experience

Dr. Marine Gogia, a distinguished Public Health Specialist and Patient Advocate, has amassed extensive experience in public health, harm reduction, and infectious disease control. Currently a Programs Director at the Georgian Harm Reduction Network (GHRN), she leads critical projects such as the Global Fund initiative to prevent HIV/AIDS and minimize drug-related harm. Her role encompasses both management and research, with notable studies on HIV self-testing and Hepatitis C elimination. Dr. Gogia has also contributed as a Co-chair at the European AIDS Treatment Group (EATG), where she provides technical expertise and strategic direction. Her prior roles include consulting for WHO and the Global Fund, and serving as a Program Coordinator at Curatio International Foundation. Her work reflects a commitment to improving health outcomes and advocating for marginalized communities through rigorous research and strategic program implementation.

Research Interest

Dr. Marine Gogia’s research interests center around public health, with a particular focus on HIV/AIDS, harm reduction, and epidemiology. She is dedicated to advancing strategies for combating HIV and hepatitis C, especially among vulnerable populations such as people who inject drugs (PWID) and marginalized groups. Her work involves evaluating and improving harm reduction programs, assessing risky behaviors, and enhancing access to healthcare services through innovative research methodologies like simplified bio-behavioral surveillance surveys. Dr. Gogia is also actively involved in policy advocacy and capacity building, contributing to global health guidelines and strategies. Her research aims to bridge gaps in healthcare access and improve the effectiveness of public health interventions, with significant contributions to regional and international efforts in infectious disease control and prevention.

Research Skills

Dr. Marine Gogia possesses exceptional research skills demonstrated through her extensive experience in public health and epidemiology. Her expertise includes conducting bio-behavioral surveillance surveys, operational research, and evaluating HIV and hepatitis C testing and treatment programs. Dr. Gogia excels in designing and implementing research methodologies, such as the BSS-Lite survey, to assess risky behaviors among people who inject drugs (PWIDs). She is adept at analyzing data related to HIV self-testing acceptability and identifying barriers to HCV program enrollment. Her research skills are further evident in her contributions to studies on legal and regulatory barriers, and her ability to synthesize complex information into actionable insights for policy-making. Dr. Gogia’s proficiency extends to training and consultancy, where she effectively translates research findings into practical solutions for public health challenges. Her work consistently reflects a high level of analytical rigor and a commitment to advancing public health outcomes.

Awards and Recognition

Maryam has received several certificates of participation and training, including the Training of Trainers certificates, a peer reviewer course, and various certificates in statistical analysis and genetic research. These accolades demonstrate her commitment to continuous learning and professional development.

Conclusion

Maryam Qasim is a promising candidate for the Best Researcher Award due to her significant contributions to antimicrobial resistance research and molecular genetics. Her work, although primarily regional, has the potential to address broader health issues through applied research and collaborative efforts. Her academic background and continued professional development through various certifications further strengthen her candidacy.

Publications Top Notes

  1. Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024
    • Authors: Tohme, R.A., Shadaker, S., Adamia, E., Schumacher, I.T., Gabunia, T.
    • Year: 2024
  2. Piloting a Simplified Bio-Behavioural Survey Methodology, the BBS-Lite, Among People Who Inject Drugs in Georgia
    • Authors: Gogia, M., Ruadze, E., Kasrashvili, T., Khonelidze, I., Stvilia, K.
    • Year: 2024
  3. Recommendations for Defining Preventable HIV-Related Mortality for Public Health Monitoring in the Era of Getting to Zero: An Expert Consensus
    • Authors: Croxford, S.E., Martin, V., Lucas, S.B., Waters, L.J., Sullivan, A.K.
    • Year: 2023
    • Citations: 1
  4. Barriers of Linkage to HCV Viremia Testing Among People Who Inject Drugs in Georgia
    • Authors: Butsashvili, M., Abzianidze, T., Kamkamidze, G., Nasrullah, M., Averhoff, F.
    • Year: 2022
    • Citations: 2
  5. Hidden Populations: Risk Behaviours in Drug-Using Populations in the Republic of Georgia Through Subsequent Peer-Driven Interventions
    • Authors: Lawlor, C., Gogia, M., Kirtadze, I., Jikia, G., Zurashvili, T.
    • Year: 2021
    • Citations: 1
  6. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
    • Authors: Farhoudian, A., Radfar, S.R., Ardabili, H.M., Yitayih, Y., Zhao, M.
    • Year: 2021
    • Citations: 44
  7. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
    • Authors: Radfar, S.R., De Jong, C.A.J., Farhoudian, A., Zhao, M., Zonoozi, A.K.
    • Year: 2021
    • Citations: 53
  8. Integration of Hepatitis C Treatment at Harm Reduction Centers in Georgia—Findings from a Patient Satisfaction Survey
    • Authors: Butsashvili, M., Kamkamidze, G., Kajaia, M., Japaridze, M., Averhoff, F.
    • Year: 2020
    • Citations: 9
  9. Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
    • Authors: Stvilia, K., Spradling, P.R., Asatiani, A., Averhoff, F., Nasrullah, M.
    • Year: 2019
    • Citations: 17
  10. Hidden Populations: Discovering the Differences Between the Known and the Unknown Drug-Using Populations in the Republic of Georgia
    • Authors: Gogia, M., Lawlor, C., Shengelia, N., Stvilia, K., Raymond, H.F.
    • Year: 2019
    • Citations: 1

 

Joana Sousa | Nursing and Health | Best Researcher Award

Published on by World Science Awards

Prof Dr. Joana Sousa | Nursing and Health | Best Researcher Award

Professor at Polytechnic Institute of Leiria , Portugal .

Joana Sofia Dias Pereira de Sousa is an accomplished nursing professional with a strong academic and clinical background. She holds a Master’s Degree in Nursing and a Doctorate in Nursing from the Portuguese Catholic University. Her extensive education includes several postgraduate certificates in specialized fields such as Gerontogeriatric Nursing, Nursing Information Systems, Economics and Management in Health Organizations, and Medical-Surgical Nursing. Additionally, she has completed comprehensive training programs, including systematic review methodologies and pedagogical training for trainers.

Profile

Education

Joana Sofia Dias Pereira de Sousa has an extensive educational background in nursing, marked by her commitment to advancing her knowledge and expertise in the field. She completed her Nursing License Degree from the Nursing School of Coimbra, Portugal, in 2003, followed by a Master’s Degree in Nursing from the Institute of Health Sciences at the Portuguese Catholic University in 2009. Her master’s thesis focused on the care strategies employed by family members to manage confusion in hospitalized patients. Continuing her academic journey, she earned her Doctorate in Nursing (PhD) from the same institution in 2020, where her doctoral dissertation centered on “Self-care in Patients with Heart Failure.” In addition to these degrees, Dr. Sousa has also pursued various postgraduate certifications in Gerontogeriatric Nursing, Nursing Information Systems, and Economics and Management in Health Organizations, highlighting her dedication to specialized knowledge within her field.

Professional Experience

Dr. Sousa’s professional career is distinguished by her dual roles in academia and clinical practice. She currently serves as an Adjunct Teacher at the Instituto Politécnico de Leiria, Escola Superior de Saúde, Portugal, where she has been a faculty member since 2022. Her teaching career also includes previous roles as an Invited Adjunct Teacher at the same institution and the Escola Superior de Enfermagem de Coimbra. In the clinical domain, Dr. Sousa has extensive experience working at the Centro Hospitalar e Universitário de Coimbra, where she held positions ranging from Nurse to Nurse Specialist, and eventually, Principal Nurse. Her clinical expertise is particularly strong in Medical-Surgical Nursing, where she applied her specialized knowledge to improve patient outcomes in a hospital setting.

Research Interest

Dr. Sousa’s research interests lie primarily in the field of health sciences, with a specific focus on nursing. Her doctoral research on self-care in patients with heart failure reflects her interest in chronic disease management and patient-centered care. She is particularly interested in exploring how nurses can empower patients to take an active role in managing their health, which is crucial in chronic conditions like heart failure. Additionally, her postgraduate training in Nursing Information Systems and Gerontogeriatric Nursing indicates a broader interest in integrating technology into nursing practice and addressing the unique needs of elderly populations.

 Research Skills

In addition to her specialized knowledge in nursing, Dr. Sousa possesses a range of skills that complement her professional and research endeavors. She is proficient in English at an advanced level (C1) and has intermediate proficiency in Spanish and French, which enhances her ability to collaborate internationally and contribute to global research initiatives. Her skills in systematic review methodologies, gained through comprehensive training programs, enable her to critically assess and synthesize research findings, further supporting her work in evidence-based practice. Her technical skills are also evident in her contributions to technical production and her participation in both national and international events.

Awards and Recognition

Throughout her career, Dr. Sousa has garnered recognition for her contributions to the field of nursing, though specific awards are not detailed in her curriculum vitae. Her consistent involvement in research, teaching, and clinical practice has earned her a respected position within the nursing community. Her ability to publish in specialized journals, contribute to conference proceedings, and collaborate with a wide network of co-authors demonstrates her standing as a recognized expert in her field. Her ongoing role as a Co-Principal Investigator in projects at the Instituto Politécnico de Leiria further underscores her leadership and commitment to advancing nursing education and practice.

Conclusion

Dr. Joana Sofia Dias Pereira de Sousa is a strong candidate for a Best Researcher Award in the field of Nursing and Health Sciences. Her academic qualifications, combined with her extensive research contributions, demonstrate her commitment to advancing knowledge and improving patient care. Her ability to publish in specialized journals, collaborate with a wide network of researchers, and contribute to the academic and clinical development of the nursing profession make her a deserving candidate for this recognition.

Publications Top Notes

  • “Dimensions of clinical leadership among pre-registration nursing students: A cross-sectional study between two countries”
    📅 Year: 2024
    📰 Journal: Nurse Education in Practice
    ✍️ Authors: Baron, S., Grinberg, K., Sousa, J.P., Scammell, J., Warshawski, S.
  • “GOOD PRACTICES IN THE PRE-ANALYTICAL PHASE OF BLOOD CULTURES: A QUASI-EXPERIMENTAL STUDY IN AN EMERGENCY DEPARTMENT”
    📅 Year: 2024
    📰 Journal: Millenium: Journal of Education, Technologies, and Health
    ✍️ Authors: Baptista, T., Sousa, J.
  • “Exploring Professional Practice Environments and Organisational Context Factors Affecting Nurses’ Adoption of Evidence-Based Practice: A Scoping Review”
    📅 Year: 2024
    📰 Journal: Healthcare (Switzerland)
    ✍️ Authors: Furtado, L., Coelho, F., Mendonça, N., Santos, C., Araújo, B.
  • “Interventions to Minimize Medication Error by Nurses in Intensive Care: A Scoping Review Protocol”
    📅 Year: 2023
    📰 Journal: Nursing Reports
    ✍️ Authors: Coelho, F., Furtado, L., Mendonça, N., Santos, C., Sousa, J.P.
  • “A Pilot Randomised Controlled Trial on the Effectiveness of an Anti-Stress Ball Technique for Pain Reduction during Vascular Access Cannulation in Haemodialysis Patients”
    📅 Year: 2023
    📰 Journal: Nursing Reports
    ✍️ Authors: Dinis, M., Sousa, J.P.
  • “Changes in Clinical Training for Nursing Students during the COVID-19 Pandemic: A Scoping Review”
    📅 Year: 2023
    📰 Journal: Nursing Reports
    ✍️ Authors: Lobão, C., Coelho, A., Parola, V., Sousa, J.P., Gonçalves, R.
  • “NURSING CARE AT CRITICAL CARE PATIENT INTER-HOSPITAL TRANSFER: A SCOPING REVIEW PROTOCOL”
    📅 Year: 2022
    📰 Journal: Millenium: Journal of Education, Technologies, and Health
    ✍️ Authors: Carvalho, C., Sousa, J.P.
  • “Nursing Care in Peripheral Intravenous Catheter (PIVC): Protocol of a Best Practice Implementation Project”
    📅 Year: 2022
    📰 Journal: Nursing Reports
    ✍️ Authors: Catarino, F., Lourenço, C., Correia, C., Cardoso, D., Costeira, C.R.
  • “Helmet-Noninvasive Ventilation for Hospitalized Critically Ill COVID-19 Patients: Has Vaccination and the New Variants Changed Evidence?”
    📅 Year: 2022
    📰 Journal: Nursing Reports
    ✍️ Authors: Neves, H., Parola, V., Bernardes, R.A., Catela, N., Cruz, A.
  • “Burnout and Nursing Care: A Concept Paper”
    📅 Year: 2022
    📰 Journal: Nursing Reports
    ✍️ Authors: Parola, V., Coelho, A., Neves, H., Sousa, J.P., Catela, N.